# ikarovec jobs and careers

> 0 open roles at ikarovec as of October 23, 2026. Source: https://www.thejobsmap.com/company/ikarovec

The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Norwich, United Kingdom |
| Founded | 2018 |
| Employees | 1 to 10 |
| Total funding | $2.5M |
| Industries | Biotechnology, Health Care, Life Sciences, Medical Devices |
| Website | https://ikarovec.com |

## Leadership

- Robert Haigh, CEO + Executive Chair
- Katie Binley, Chief Scientific Officer

## Common questions

### Is ikarovec hiring right now?

ikarovec has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on ikarovec's careers site.

### Where is ikarovec headquartered?

ikarovec is headquartered in Norwich, United Kingdom and was founded in 2018.

### Who leads ikarovec?

Robert Haigh, CEO + Executive Chair, is at the top of ikarovec's org chart.

### How do I apply for a job at ikarovec?

Pick a role on ikarovec's TheJobsMap page and select Apply. Every listing links to the original posting on ikarovec's own careers site, so you apply directly with the employer.